The LASSO regression, optimized using 10-fold cross-validation (Figure 7a), selected six genes: NSUN2, IGF2BP2, YTHDC1, ALKBH5, TRDMT1, and ZC3H13 as the most predictive for overall survival in BLCA patients. The gene discussed is ALKBH5; the disease is bladder transitional cell carcinoma.